A carregar...
A case of malignant insulinoma responsive to somatostatin analogs treatment
BACKGROUND: Insulinoma is a rare tumour representing 1–2% of all pancreatic neoplasms and it is malignant in only 10% of cases. Locoregional invasion or metastases define malignancy, whereas the dimension (> 2 cm), CK19 status, the tumor staging and grading (Ki67 > 2%), and the age of onset (&...
Na minha lista:
| Publicado no: | BMC Endocr Disord |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6307122/ https://ncbi.nlm.nih.gov/pubmed/30591061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-018-0325-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|